Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HUMAN RHO IMMUNE GLOBULIN for Alloimmunisation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 26 adverse event reports in the FDA FAERS database where HUMAN RHO IMMUNE GLOBULIN was used for Alloimmunisation.

Most Reported Side Effects for HUMAN RHO IMMUNE GLOBULIN

Side Effect Reports % Deaths Hosp.
No adverse event 238 19.7% 0 2
Drug ineffective 201 16.7% 6 77
Device issue 167 13.8% 0 1
Syringe issue 154 12.8% 0 1
Nausea 111 9.2% 7 19
Treatment failure 110 9.1% 6 88
Arthralgia 109 9.0% 6 74
Therapy non-responder 107 8.9% 7 77
Pain in extremity 104 8.6% 6 76
Therapeutic product effect decreased 104 8.6% 5 31
Joint swelling 100 8.3% 6 75
Infection 98 8.1% 6 74
Haemolysis 97 8.0% 1 6
Hepatotoxicity 96 8.0% 6 72
Musculoskeletal stiffness 96 8.0% 6 73

Other Indications for HUMAN RHO IMMUNE GLOBULIN

Product used for unknown indication (385) Prophylaxis against rh isoimmunisation (138) Immune thrombocytopenic purpura (50) Rhesus antigen negative (44) Rhesus incompatibility (43) Immune thrombocytopenia (36) Prophylaxis (31) Foetal-maternal haemorrhage (19) Pregnancy (17) Abortion spontaneous (16)

Other Drugs Used for Alloimmunisation

HUMAN IMMUNOGLOBULIN G (25) RITUXIMAB (10)

Related Pages

HUMAN RHO IMMUNE GLOBULIN Full Profile All Alloimmunisation Drugs HUMAN RHO IMMUNE GLOBULIN Demographics HUMAN RHO IMMUNE GLOBULIN Timeline